Prime Medicine, Inc.

Prime Medicine, Inc.

PRME · Nasdaq

Prime Medicine, Inc. (PRME) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Prime Medicine, Inc. in 2026. The next earnings report is expected on October 30, 2026.

Earnings calendar

Next earnings date

30 Oct 2026

In 71 days

EPS estimate

-0.23

Revenue estimate

7.1M

Past earnings

06 Aug 2026
EPS actual
-0.28 (-6.9%)
estimate -0.26
Revenue actual
1.1M (-51.1%)
estimate 2.3M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
07 May 2026
EPS actual
-0.28 (-11.6%)
estimate -0.25
Revenue actual
856.0K (-63.2%)
estimate 2.3M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
03 Mar 2026
EPS actual
-0.22 (+12.5%)
estimate -0.25
Revenue actual
842.0K (-34.6%)
estimate 1.3M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
07 Nov 2025
EPS actual
-0.32 (-26.5%)
estimate -0.25
Revenue actual
1.2M (-52.5%)
estimate 2.6M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Latest earnings analysis

Prime Medicine, Inc. missed consensus estimates in its latest earnings report, with EPS of $-0.275 versus an estimate of $-0.2572 and revenue of $1.1 million, 51.1% below expectations. In the prior report both EPS and revenue were also below expectations.

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. It offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the Prime Editor to a specific genomic location and provides a template for making the desired edit to the target DNA sequence. The company was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.

Sector
Healthcare
Industry
Biotechnology
Country
United States
Exchange
Nasdaq
CEO
Allan Reine
Employees
214
IPO date
20 Oct 2022
ISIN
US74168J1016
Website
primemedicine.com

Frequently asked questions

When does Prime Medicine, Inc. (PRME) next report earnings?

Prime Medicine, Inc. (PRME) is scheduled to report earnings on October 30, 2026.

What was Prime Medicine, Inc.'s most recent earnings date?

Prime Medicine, Inc. (PRME) last reported earnings on August 6, 2026.

Where is Prime Medicine, Inc. stock listed?

Prime Medicine, Inc. (PRME) is listed on Nasdaq.